BockbraderHN, WescheD, MillerR, et al.: A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet, 2010; 49:661–669.
2.
Pregabalin (Lyrica®) [package insert]. New York: Pfizer Parke-Davis, 2004.
3.
EisenbergE, RiverY, ShifrinA, et al.: Antiepileptic drugs in the treatment of neuropathic pain. Drugs, 2007; 67:1265–1289.
4.
BrilV, EnglandJ, FranklinGM, et al.; American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, American Academy of Physical Medicine and Rehabilitation: Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 2011; 76:1758–1765.
5.
BennettMI, LairdB, van LitsenburgC, NimourM: Pregabalin for the management of neuropathic pain in adults with cancer: A systematic review of the literature. Pain Med, 2013; 14:1681–1688.
6.
MishraS, BhatnagarS, GoyalGN, et al.: A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care, 2012; 29:177–182.
7.
NishiharaM, AraiYC, YamamotoY, et al.: Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician, 2013; 16:E547–E552.
